Circulating microRNA-126 increases after different forms of endurance exercise in healthy adults

European Journal of Preventive Cardiology

Volumn 21, Issue 4, 2014, Pages 484-491

  Uhlemann, Madlen ^a   Möbius Winkler, Sven ^a   Fikenzer, Sven ^b   Adam, Jennifer ^a   Redlich, Maren ^a   Möhlenkamp, Stefan ^c   Hilberg, Thomas ^d   Schuler, Gerhard C ^a   Adams, Volker ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Saarland University of Applied Sciences   (Germany)

^c Department of Cardiology Hospital Bethanien Moers   (Germany)

^d UNIVERSITY OF WUPPERTAL   (Germany)

Author keywords

endothelial damage; Exercise; microRNA; plasma

Indexed keywords

MICRORNA; MICRORNA 126; MIRNA 133; UNCLASSIFIED DRUG; GENETIC MARKER; MIRN126 MICRORNA, HUMAN; MIRN133 MICRORNA, HUMAN;

ADULT; ARTICLE; BICYCLE; BLOOD LEVEL; CARDIOPULMONARY EXERCISE TEST; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENDURANCE TRAINING; FEMALE; HUMAN; MALE; MAXIMAL SYMPTOM LIMITED EXERCISE TEST; PRIORITY JOURNAL; RESISTANCE TRAINING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUNNING; BLOOD; COMPARATIVE STUDY; CYCLING; ENDURANCE; GENETIC MARKER; GENETICS; METABOLISM; PATHOLOGY; TIME; UPREGULATION;

ADULT; BICYCLING; ENDOTHELIAL CELLS; FEMALE; GENETIC MARKERS; HUMANS; MALE; MICRORNAS; PHYSICAL ENDURANCE; RESISTANCE TRAINING; RUNNING; TIME FACTORS; UP-REGULATION;

EID: 84896474219     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/2047487312467902     Document Type: Article

References (45)

1. Small EM, Olson EN. Pervasive role of microRNAs in cardiovascular biology. Nature. 2011 ; 469: 336-342
2. Bentwich I, Avniel A, Karov Y, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005 ; 37: 766-770
3. Small EM, Frost RJA, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation. 2010 ; 121: 1022-1032
4. Latronico MVG, Catalucci D, Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res. 2007 ; 101: 1225-1236
5. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol. 2011 ; 80: 193-208
6. Cho WC. Circulating microRNAs as minimally invasive biomarkers for cancer theragnosis and prognosis. Front Genet 2011; 2: 7. DOI: 10.3389/fgene.2011. 00007.
7. Adachi T, Nakanishi M, Otsuka Y, et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem. 2010 ; 56: 1183-1185
8. Lavie CJ, Milani RV. Cardiac rehabilitation and exercise training in secondary coronary heart disease prevention. Prog Cardiovasc Dis. 2011 ; 53: 397-403
9. Adams V, Döring C, Schuler G. Impact of physical exercise on alterations in the skeletal muscle in patients with chronic heart failure. Front Biosci. 2008 ; 13: 302-311
10. Linke A, Erbs S, Hambrecht R. Effects of exercise training upon endothelial function in patients with cardiovascular disease. Front Biosci. 2008 ; 13: 424-432
11. Haram PM, Kemi OJ, Wisloff U. Adaptation of endothelium to exercise training: Insights from experimental studies. Front Biosci. 2008 ; 13: 336-346
12. Hambrecht R, Adams V, Erbs S, et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003 ; 107: 3152-3158
13. Sonnenschein K, Horváth T, Mueller M, et al. Exercise training improves in-vivo endothelial repair capacity of early endothelial progenitor cells in subjects with metabolic syndrome. Eur J Cardiovasc Prev Rehabil. 2011 ; 18: 406-414
14. Van Craenenbroeck E, Hoymans V, Beckers P, et al. Exercise training improves function of circulating angiogenic cells in patients with chronic heart failure. Basic Res Cardiol. 2010 ; 105: 665-676
15. Möbius-Winkler S, Hilberg T, Menzel K, et al. Time-dependent mobilization of circulating progenitor cells during strenuous exercise in healthy individuals. J Appl Physiol. 2009 ; 107: 1943-1950
16. Van Craenenbroeck EMF, Vrints CJ, Haine SE, et al. A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile. J Appl Physiol. 2008 ; 104: 1006-1013
17. Lenk K, Uhlemann M, Schuler G, et al. Role of endothelial progenitor cells in the beneficial effects of physical exercise on atherosclerosis and coronary artery disease. J Appl Physiol. 2011 ; 111: 321-328
18. Chaar V, Romana M, Tripette J, et al. Effect of strenuous physical exercise on circulating cell-derived microparticles. Clin Hemorheol Microcirc. 2011 ; 47: 15-25
19. Boos CJ, Blann AD, Lip GYH. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol. 2006 ; 48: 1538-1547
20. Boos CJ, Balakrishnan B, Lip GYH. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction. Ann Med. 2008 ; 40: 66-73
21. Adams V, Linke A, Breuckmann F, et al. Circulating progenitor cells decrease immediately after marathon race in advanced-age marathon runners. Eur J Cardiovasc Prev Rehabil. 2008 ; 15: 602-607
22. Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease / novelty and significance. Circ Res. 2010 ; 107: 677-684
23. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008 ; 105: 10513-10518
24. Hambrecht R, Adams V, Gielen S, et al. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol. 1999 ; 33: 174-179
25. Chung ES, Packer M, Lo KH, et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-αlpha, in patients with moderate-to-severe heart failure. Circulation. 2003 ; 107: 3133-3140
26. Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010 ; 391: 73-77
27. Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010 ; 31: 659-666
28. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009 ; 106: 4402-4407
29. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes / novelty and significance. Circ Res. 2010 ; 107: 810-817
30. Tsui NBY, Ng EKO, Lo YMD. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002 ; 48: 1647-1653
31. Rabinowits G, Gercel-Taylor C, Day JM, et al. Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer. 2009 ; 10: 42-46
32. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008 ; 3: e3694 - e3694
33. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008 ; 10: 1470-1476
34. Lehmann BD, Paine MS, Brooks AM, et al. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 2008 ; 68: 7864-7871
35. Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010 ; 38: 7248-7259
36. Ji X, Takahashi R, Hiura Y, et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem. 2009 ; 55: 1944-1949
37. Kasikcioglu E, Oflaz H, Oncul A, et al. The trivest in overreaching syndrome: Cardiac fatigue, muscular weakness, and vascular dysfunction. Int J Cardiol. 2008 ; 127: 417-419
38. Van Solingen C, Seghers L, Bijkerk R, et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med. 2009 ; 13: 1577-1585
39. Kuhnert F, Mancuso MR, Hampton J, et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development. 2008 ; 135: 3989-3993
40. Fish JE, Santoro MM, Morton SU, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008 ; 15: 272-284
41. Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008 ; 15: 261-271
42. Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006 ; 38: 228-233
43. Townley-Tilson WHD, Callis TE, Wang D. MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol. 2010 ; 42: 1252-1255
44. Clarkson PM, Nosaka K, Braun B. Muscle function after exercise-induced muscle damage and rapid adaptation. Med Sci Sports Exerc. 1992 ; 24: 512-520
45. Warhol MJ, Siegel AJ, Evans WJ, et al. Skeletal muscle injury and repair in marathon runners after competition. Am J Pathol. 1985 ; 118: 331-339